"Cell Hypoxia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition of decreased oxygen content at the cellular level.
| Descriptor ID |
D015687
|
| MeSH Number(s) |
G03.197.300 G04.270.300
|
| Concept/Terms |
Cell Hypoxia- Cell Hypoxia
- Cell Hypoxias
- Hypoxia, Cell
- Hypoxias, Cell
- Hypoxia, Cellular
- Cellular Hypoxia
- Cellular Hypoxias
- Hypoxias, Cellular
- Anoxia, Cellular
- Anoxias, Cellular
- Cellular Anoxia
- Cellular Anoxias
- Cell Anoxia
- Anoxia, Cell
- Anoxias, Cell
- Cell Anoxias
|
Below are MeSH descriptors whose meaning is more general than "Cell Hypoxia".
Below are MeSH descriptors whose meaning is more specific than "Cell Hypoxia".
This graph shows the total number of publications written about "Cell Hypoxia" by people in this website by year, and whether "Cell Hypoxia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 1 | 4 | 5 |
| 2007 | 1 | 3 | 4 |
| 2008 | 1 | 8 | 9 |
| 2009 | 0 | 3 | 3 |
| 2010 | 0 | 4 | 4 |
| 2011 | 0 | 4 | 4 |
| 2012 | 1 | 3 | 4 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 4 | 4 |
| 2015 | 0 | 5 | 5 |
| 2016 | 0 | 3 | 3 |
| 2017 | 0 | 4 | 4 |
| 2018 | 0 | 3 | 3 |
| 2019 | 0 | 2 | 2 |
| 2020 | 0 | 2 | 2 |
| 2021 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell Hypoxia" by people in Profiles.
-
The Effect of the Classical TSPO Ligand PK 11195 on In Vitro Cobalt Chloride Model of Hypoxia-like Condition in Lung and Brain Cell Lines. Biomolecules. 2022 Sep 29; 12(10).
-
4R-cembranoid protects neuronal cells from oxygen-glucose deprivation by modulating microglial cell activation. Brain Res Bull. 2022 02; 179:74-82.
-
Co-Culturing of Endothelial and Cancer Cells in a Nanofibrous Scaffold-Based Two-Layer System. Int J Mol Sci. 2020 Jun 10; 21(11).
-
Bioreductively Activatable Prodrug Conjugates of Combretastatin A-1 and Combretastatin A-4 as Anticancer Agents Targeted toward Tumor-Associated Hypoxia. J Nat Prod. 2020 04 24; 83(4):937-954.
-
Imatinib revives the therapeutic potential of metformin on ewing sarcoma by attenuating tumor hypoxic response and inhibiting convergent signaling pathways. Cancer Lett. 2020 01 28; 469:195-206.
-
Prostate Cancer Energetics and Biosynthesis. Adv Exp Med Biol. 2019; 1210:185-237.
-
Acid-Induced Downregulation of ASS1 Contributes to the Maintenance of Intracellular pH in Cancer. Cancer Res. 2019 02 01; 79(3):518-533.
-
Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy. J Clin Invest. 2018 11 01; 128(11):5137-5149.
-
Mitochondrial dysfunction in human immunodeficiency virus-1 transgenic mouse cardiac myocytes. J Cell Physiol. 2019 04; 234(4):4432-4444.
-
Myocardial reparative functions of exosomes from mesenchymal stem cells are enhanced by hypoxia treatment of the cells via transferring microRNA-210 in an nSMase2-dependent way. Artif Cells Nanomed Biotechnol. 2018 Dec; 46(8):1659-1670.